Ethacizine

Ethacizine
Clinical data
Trade names	Ethacizin
AHFS/Drugs.com	International Drug Names
ATC code	C01BC09 (WHO) ;
Legal status
Legal status	Prescription only (RU);
Pharmacokinetic data
Bioavailability	~40% (oral)
Protein binding	90%
Metabolism	Extensive hepatic
Elimination half-life	2.5 hours
Identifiers
	IUPAC name ethyl N-[10-[3-(diethylamino)propanoyl]phenothiazin-2-yl]carbamate;
CAS Number	33414-33-4 ;
PubChem CID	107841;
ChemSpider	96982 ;
UNII	FE5SPV1Z6G;
CompTox Dashboard (EPA)	DTXSID50187057 ;
Chemical and physical data
Formula	C22H27N3O3S
Molar mass	413.54 g/mol g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CCN(CC)CCC(=O)N1C2=CC=CC=C2SC3=C1C=C(C=C3)NC(=O)OCC;
	InChI InChI=1S/C22H27N3O3S/c1-4-24(5-2)14-13-21(26)25-17-9-7-8-10-19(17)29-20-12-11-16(15-18(20)25)23-22(27)28-6-3/h7-12,15H,4-6,13-14H2,1-3H3,(H,23,27) ; Key:PQXGNJKJMFUPPM-UHFFFAOYSA-N ;

Ethacizine (ethacyzine) is a class Ic antiarrhythmic agent, related to moracizine. It is used in Russia and some other CIS countries for the treatment of severe and/or refractory ventricular and supraventricular arrhythmias, especially those accompanied by organic heart disease. It is also indicated as a treatment of refractory tachycardia associated with Wolff–Parkinson–White syndrome.^[1]

It is manufactured under the brand name Ethacizin (Этацизин) by Olainfarm.^[2]

References

^ ^a ^b "Этацизин (Ethacyzin) Prescribing Information. VIDAL Drug Compendium" (in Russian). Retrieved 5 February 2014.
^ "Этацизин—4DOKTOR.RU Drug Information Handbook" (in Russian). Retrieved 5 February 2014.

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.

[PI-1] "Этацизин (Ethacyzin) Prescribing Information. VIDAL Drug Compendium" (in Russian). Retrieved 5 February 2014.

[2] "Этацизин—4DOKTOR.RU Drug Information Handbook" (in Russian). Retrieved 5 February 2014.

[1]

[2]